Synergy Pharmaceuticals LLC
(Other OTC/NBB : SGYP)

( )
SGYP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
0.28%21.551.7%$182.31m
VRXValeant Pharmaceuticals International, Inc.
1.35%27.7514.1%$163.28m
BHCBausch Health Cos., Inc.
1.35%27.750.0%$118.60m
GWPHGW Pharmaceuticals Plc
-4.52%106.016.2%$79.85m
MDCOThe Medicines Co.
-3.64%50.8920.2%$77.88m
JAZZJazz Pharmaceuticals Plc
0.38%133.822.3%$62.86m
SAGESAGE Therapeutics, Inc.
-2.26%140.798.6%$50.65m
PRGOPerrigo Co. Plc
-0.77%48.026.8%$47.61m
ENDPEndo International Plc
-3.03%4.168.8%$44.77m
UTHRUnited Therapeutics Corp.
1.18%89.5314.3%$39.39m
HZNPHorizon Therapeutics Plc
-1.62%29.816.6%$38.74m
ICPTIntercept Pharmaceuticals, Inc.
-1.04%83.0516.9%$38.71m
ICLRICON plc
1.41%152.424.2%$37.87m
CTLTCatalent, Inc.
-0.89%49.112.4%$31.43m
ARGXargenx SE
0.58%137.380.0%$26.76m

Company Profile

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.